price
HA
NASDAQ · HALO
Halozyme Therapeutics, Inc.
Healthcare · Biotechnology
$130.91
Down-$0.27 (-0.21%)
Updated Nov 2, 2026, 9:10 AM
SID Score
7.8/10
Composite research score
Smart Money
47/100
Neutral
- Market cap
- 7.28B
- P/E ratio
- 12.19
- Dividend yield
- 0.00%
- 52-week range
- $61.23 – $134.00
- Volume
- 1.4M
- Avg. volume
- 2.52M
Price performance · HALO
HALO price history
1M range · 0 trading sessions · Daily adjusted prices
HALO does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest HALO news
The latest Smart Investors Daily articles mentioning HALO.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…